CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Williams Timothy SVP & General Counsel | Grant or award | +125,000 | 419,884 | ||
| 2026-02-18 | Moran Kevin Patrick SVP, CFO & Treasurer | Grant or award | +125,000 | 453,822 | ||
| 2026-02-18 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +525,000 | 2,860,731 | ||
| 2025-08-07 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +10,000 | $4.15 | $42K | 2,335,731 |
| 2025-06-13 | Mitchell Stephen Ray Director | Sale | −7,000 | $4.59 | $32K | 97,082 |
| 2025-06-05 | Mitchell Stephen Ray Director | Grant or award | +59,225 | 104,082 | ||
| 2025-06-05 | Chrousos Phaedra Director | Grant or award | +59,225 | 123,350 | ||
| 2025-06-05 | DUGAN RICHARD W Director | Grant or award | +59,225 | 177,454 | ||
| 2025-06-05 | Honore Tage Director | Grant or award | +59,225 | 123,469 | ||
| 2025-06-05 | Ward Anne Sempowski Director | Grant or award | +59,225 | 119,067 | ||
| 2025-05-21 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +9,519 | $4.40 | $42K | 2,325,250 |
| 2025-05-21 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +481 | $4.39 | $2K | 2,325,731 |
| 2025-05-16 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +20,000 | $4.22 | $84K | 2,315,731 |
| 2025-03-06 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $5.02 | $25K | 2,290,731 |
| 2025-03-06 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $5.01 | $25K | 2,295,731 |
| 2025-03-05 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $5.01 | $25K | 2,280,731 |
| 2025-03-05 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +5,000 | $5.03 | $25K | 2,285,731 |
| 2025-03-03 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +10,000 | $4.71 | $47K | 2,275,731 |
| 2025-03-01 | Wijkstrom Joakim SVP, Chief Marketing Officer | Shares withheld for taxes | −15,520 | $4.76 | $74K | 239,269 |
| 2025-03-01 | Birznieks Gunther SVP, Business Development | Shares withheld for taxes | −26,941 | $4.76 | $128K | 411,628 |
Page 2 of 8 · 153 trades